PAS, periodic acid Schiff
- You have accessPeroxisome Proliferator–Activated Receptor α/γ Dual Agonist Tesaglitazar Attenuates Diabetic Nephropathy in db/db MiceDae Ryong Cha, Xiaoyan Zhang, Yahua Zhang, Jing Wu, Dongming Su, Jee Young Han, Xuefen Fang, Bo Yu, Matthew D. Breyer, Youfei GuanDiabetes Aug 2007, 56 (8) 2036-2045; DOI: 10.2337/db06-1134
- You have accessRegulation of Renal Fatty Acid and Cholesterol Metabolism, Inflammation, and Fibrosis in Akita and OVE26 Mice With Type 1 DiabetesGregory Proctor, Tao Jiang, Mieko Iwahashi, Zhuowei Wang, Jinping Li, Moshe LeviDiabetes Sep 2006, 55 (9) 2502-2509; DOI: 10.2337/db05-0603
- You have accessRAGE Control of Diabetic Nephropathy in a Mouse ModelKhin-Mar Myint, Yasuhiko Yamamoto, Toshio Doi, Ichiro Kato, Ai Harashima, Hideto Yonekura, Takuo Watanabe, Harumichi Shinohara, Masayoshi Takeuchi, Koichi Tsuneyama, Noriyoshi Hashimoto, Masahide Asano, Shin Takasawa, Hiroshi Okamoto, Hiroshi YamamotoDiabetes Sep 2006, 55 (9) 2510-2522; DOI: 10.2337/db06-0221
- Diabetes Education (123)
- Epidemiology-Aging (30)
- Epidemiology-Other (230)
- Exercise (54)
- Heart Failure (6)
- Immunology (88)
- Nutrition-Clinical (55)
- Obesity-Animal (60)
- Obesity-Human (74)
- Profiles in Progress (29)
- The RISE Consortium (13)
- Therapeutic Inertia (17)
- Transplantation (16)